Cardinal Health, Inc. (CAH)

247.18USD -0.58% (-1.43)

Over 1M: +4.6%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

230 240 250
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Gross Profit: 1.8B Q3 '23 — Free Cash Flow: 1.3B Q3 '23 — Net Income: 345M Q4 '23 — Gross Profit: 1.8B Q4 '23 — Free Cash Flow: 646M Q4 '23 — Net Income: 5M Q1 '24 — Gross Profit: 1.7B Q1 '24 — Free Cash Flow: 436M Q1 '24 — Net Income: -12M Q2 '24 — Gross Profit: 1.9B Q2 '24 — Free Cash Flow: 1.1B Q2 '24 — Net Income: 368M Q3 '24 — Gross Profit: 1.9B Q3 '24 — Free Cash Flow: -139M Q3 '24 — Net Income: 261M Q4 '24 — Gross Profit: 1.9B Q4 '24 — Free Cash Flow: 1.9B Q4 '24 — Net Income: 235M Q1 '25 — Gross Profit: 1.9B Q1 '25 — Free Cash Flow: -1.7B Q1 '25 — Net Income: 416M Q2 '25 — Gross Profit: 1.9B Q2 '25 — Free Cash Flow: -495M Q2 '25 — Net Income: 400M Q3 '25 — Gross Profit: 2.1B Q3 '25 — Free Cash Flow: 2.8B Q3 '25 — Net Income: 506M Q4 '25 — Gross Profit: 2.2B Q4 '25 — Free Cash Flow: 1.3B Q4 '25 — Net Income: 239M Q1 '26 — Gross Profit: 2.3B Q1 '26 — Free Cash Flow: 865M Q1 '26 — Net Income: 450M Q2 '26 — Gross Profit: 2.4B Q2 '26 — Free Cash Flow: 555M Q2 '26 — Net Income: 467M -1B 0 1B 2B 3B
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Gross Profit Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

5.2
ROIC 218.0%
SBC / sales 0.14%
OE margin 1.6%
Accruals -6.0%
ROCE 19.5%
OCF / EBIT 2.0×
ROA 3.0%
FCF margin 1.8%
OCF margin 2.0%
ROE —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

9.6
EV/Sales 0.24×
EV/OE 14.7×
FCF yield 7.9%
EV/GP 6.3×
P/C 11.4×
Div. yield 0.85%
EV/EBIT 23.5×
P/E 33.5×
Fwd P/E —
P/B —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

8.5
Segment HHI 0.86 HHI
RPO / sales —
RPO growth —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.9
ND/EBITDA -0.062
Current ratio 0.88×
Debt payback 0.85 yr
F-score 8.0 pts
Cash / Debt 0.57×
Payout 28.6%
Quick ratio 0.49×
Cash runway —
Debt / Eq —
Equity / Assets —
Net debt / Eq —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.5
Sales/sh Y/Y +16.6%
Sales Q/Q +18.8%
EBIT Y/Y +14.9%
EPS Y/Y +12.1%
Div. growth -0.61%
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.